Department of Nutrition and Dietetics, Faculty of Health Sciences, Near East University, Nicosia, Cyprus.
DESAM Research Institute, Near East University, Nicosia, Cyprus.
Infect Dis Obstet Gynecol. 2022 Feb 16;2022:1157793. doi: 10.1155/2022/1157793. eCollection 2022.
Human immunodeficiency virus (HIV) can be transmitted from mothers to their babies during pregnancy, delivery through vaginal fluids or breastfeeding. As false positivity anti-HIV results due to pregnancy could be detected and no relevant study have been reported in Northern Cyprus so far, we aimed to estimate the false anti-HIV positivity rate in pregnant women.
A total of 11.977 women admitted to Near East University Hospital between 2015 and 2018 were involved. The fourth generation anti-HIV-1/2 ELISA test was carried out by chemiluminescence enzyme immunoassay. Positive results were confirmed by real-time polymerase chain reaction (rt-PCR). SPSS (Statistical Package for the Social Sciences) Demo Ver 22 program was used for statistical analysis and significance (p<0.05) was measured by Person Chi-Square and Fisher's Exact tests.
Anti-HIV-1/2 ELISA test was positive in 7 (0.3%) of pregnant and 11 (0.1%) of non-pregnant women. HIV RNA was not detected in any pregnant however, was detected in 2 (0.02%) of non pregnant. S/Co titer of pregnant and non pregnant who have positive anti-HIV-test without viral load was x̄=2.68±1.64 (1.34-5.20) and x̄=8.63±7.68 (1.56-20.98) respectively. False positivity was significantly higher in pregnants compared to non-pregnants (p=0.033).
False positivity can be encountered during pregnancy therefore, positive anti-HIV-1/2 ELISA results should be confirmed with molecular techniques before initiating antiretroviral treatment.
人类免疫缺陷病毒(HIV)可在妊娠期间通过阴道液或母乳喂养从母亲传播给婴儿。由于妊娠导致的抗 HIV 假阳性结果可以被检测到,而北塞浦路斯迄今为止尚未有相关研究报道,因此我们旨在估计孕妇中抗 HIV 假阳性率。
共有 2015 年至 2018 年间在中东大学医院就诊的 11977 名妇女参与了研究。采用化学发光酶免疫分析法进行第四代抗 HIV-1/2 ELISA 检测。阳性结果通过实时聚合酶链反应(rt-PCR)确认。采用 SPSS(社会科学统计软件包)Demo Ver 22 程序进行统计分析,采用 Person Chi-Square 和 Fisher's Exact 检验测量显著性(p<0.05)。
抗 HIV-1/2 ELISA 检测在 7 名(0.3%)孕妇和 11 名(0.1%)非孕妇中呈阳性。然而,在任何孕妇中均未检测到 HIV RNA,但在 2 名(0.02%)非孕妇中检测到。具有阳性抗 HIV 检测但无病毒载量的孕妇和非孕妇的 S/Co 滴度分别为 x̄=2.68±1.64(1.34-5.20)和 x̄=8.63±7.68(1.56-20.98)。与非孕妇相比,孕妇的假阳性率显著更高(p=0.033)。
妊娠期间可能会出现假阳性,因此在开始抗逆转录病毒治疗之前,应通过分子技术确认抗 HIV-1/2 ELISA 阳性结果。